Synopsis Acne vulgaris (AV) is one of the most common skin conditions in adolescents and young adults. Due to similar pathology and clinical presentation, truncal AV is treated with the same therapeutic approach as that of facial AV. Trifarotene is a new retinoic acid receptor gamma selective topical retinoid cream formulation that is suitable for use on the face and trunk. This med fact briefs about a phase-3 clinical trial titled, Efficacy and Safety of Trifarotene 50 μg/g Cream Versus Vehicle Cream in Acne Vulgaris , from the Journal of the American Academy of Dermatology .
Authors: Jerry Tan, MD, Diane Thiboutot, MD, et al. Study brief: Objective Assessment of the efficacy and safety of trifarotene 50 μg/g cream applied once daily for 12 weeks in subjects with acne vulgaris. Study Type Phase-3, multi-center, randomized, interventional, double-blind, vehicle-controlled clinical…
